Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

NCT00446199 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
735
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer